Furthermore, our administration of the CD-RISC to a subsample six months after the initial measures of the SDRS-R, GAD, PHQ, and HTQ-PTSD for validation purposes may have undermined our comparison between the CD-RISC and the SDRS's associations with mental health symptoms. This evidence concerns the gene GAD1 and post-traumatic stress disorder.